RT Journal Article
SR Electronic
T1 Extreme purifying selection against point mutations in the human genome
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 2021.08.23.457339
DO 10.1101/2021.08.23.457339
A1 Noah Dukler
A1 Mehreen R. Mughal
A1 Ritika Ramani
A1 Yi-Fei Huang
A1 Adam Siepel
YR 2021
UL http://biorxiv.org/content/early/2021/08/23/2021.08.23.457339.abstract
AB Genome sequencing of tens of thousands of human individuals has recently enabled the measurement of large selective effects for mutations to protein-coding genes. Here we describe a new method, called ExtRaINSIGHT, for measuring similar selective effects at individual sites in noncoding as well as in coding regions of the human genome. ExtRaINSIGHT estimates the prevalance of strong purifying selection, or “ultraselection” (λs), as the fractional depletion of rare single-nucleotide variants (minor allele frequency < 0.1%) in a target set of genomic sites relative to matched sites that are putatively neutrally evolving, in a manner that controls for local variation and neighbor-dependence in mutation rate. We show using simulations that, above an appropriate threshold, λs is closely related to the average site-specific selection coefficient against heterozygous point mutations, as predicted at mutation-selection balance. Applying ExtRaINSIGHT to 71,702 whole genome sequences from gnomAD v3, we find particularly strong evidence of ultraselection in evolutionarily ancient miRNAs and neuronal protein-coding genes, as well as at splice sites. Moreover, our estimated selection coefficient against heterozygous amino-acid replacements across the genome (at 1.4%) is substantially larger than previous estimates based on smaller sample sizes. By contrast, we find weak evidence of ultraselection in other noncoding RNAs and transcription factor binding sites, and only modest evidence in ultraconserved elements and human accelerated regions. We estimate that ∼0.3–0.5% of the human genome is ultraselected, with one third to one half of ultraselected sites falling in coding regions. These estimates suggest ∼0.3–0.4 lethal or nearly lethal de novo mutations per potential human zygote, together with ∼2 de novo mutations that are more weakly deleterious. Overall, our study sheds new light on the genome-wide distribution of fitness effects for new point mutations by combining deep new sequencing data sets and classical theory from population genetics.Competing Interest StatementThe authors have declared no competing interest.